Resolution of tardive dyskinesia after addition of aripiprazole to haloperidol depot.
Kantrowitz
Joshua T
JT
Srihari
Vinod H
VH
Tek
Cenk
C
D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000068180:Aripiprazole; D003692:Delayed-Action Preparations; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy*; D006220:Haloperidol / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010879:Piperazines / Q000008:administration & dosage*; D015363:Quinolones / Q000008:administration & dosage*; D012074:Remission Induction; D012559:Schizophrenia / Q000188:drug therapy; D019966:Substance-Related Disorders / Q000150:complications
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D010879:Piperazines; D015363:Quinolones; D000068180:Aripiprazole; C033563:haloperidol decanoate; D006220:Haloperidol